These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 16154711)
1. Aromatase inhibitors may be effective in the management of advanced hepatocellular carcinoma. Altundag O; Altundag K; Turen S; Gunduz E; Atik MA Med Hypotheses; 2006; 66(6):1257. PubMed ID: 16154711 [No Abstract] [Full Text] [Related]
2. Successful targeted therapies for hepatocellular carcinoma: are we really getting there? Zhu AX Expert Rev Anticancer Ther; 2008 Apr; 8(4):499-505. PubMed ID: 18402516 [No Abstract] [Full Text] [Related]
3. Treatment with inhibitors of angiogenesis in advanced hepatocellular carcinoma: a new tool in our hands or simply a hope? Cipriani G; Mazzanti R Dig Liver Dis; 2005 Apr; 37(4):230-1. PubMed ID: 15788205 [No Abstract] [Full Text] [Related]
4. The role of somatostatin analogs in the management of hepatocellular carcinoma. D'Agostino L; Manguso F; Pivonello R; Colao A J Endocrinol Invest; 2003; 26(8 Suppl):131-3. PubMed ID: 15233229 [No Abstract] [Full Text] [Related]
5. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now. Pang RW; Poon RT Oncology; 2007; 72 Suppl 1():30-44. PubMed ID: 18087180 [TBL] [Abstract][Full Text] [Related]
6. Can metallothionein be a useful molecular marker for selecting hepatocellular carcinoma patients for platinum-based chemotherapy? Doki Y; Monden M J Gastroenterol; 2004 Dec; 39(12):1228-9. PubMed ID: 15622495 [No Abstract] [Full Text] [Related]
7. Re: Liu et al.--Estrogen receptor status in inoperable hepatocellular carcinoma. Chow PK; Hung H; Soo KC Am J Gastroenterol; 2001 Apr; 96(4):1297-8. PubMed ID: 11316190 [No Abstract] [Full Text] [Related]
9. Need of stratifying patients according to severity of underlying liver disease for hepatocellular carcinoma patients undergoing systemic therapy trials. Yeo W; Mo FK; Hui P; Chan SL Contemp Clin Trials; 2010 Mar; 31(2):135. PubMed ID: 20123038 [No Abstract] [Full Text] [Related]
10. Targeting chemokines as a therapeutic option for hepatocellular carcinoma: a reality or just a fantasy? Yu J J Gastroenterol Hepatol; 2007 May; 22(5):611-2. PubMed ID: 17444845 [No Abstract] [Full Text] [Related]